AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
HEPARIN SODIUM in Zimbabwe
6 products registered with MCAZ — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| POLI-RIN SOLUTION; INJECTION | 2024/10.2/6598 | WMT PHARMACEUTICALS | active | 6 May 2029 |
| VAXCEL SOLUTION; INJECTION | 2018/10.2/5724 | KOTRA PHARMA (M) SDN BHD | active | 5 Dec 2028 |
| HEPALIN SOLUTION; INJECTION | 2023/10.2/6494 | LINCOLN PHARMACEUTICALS LIMITED | active | 26 Oct 2028 |
| HEPARIN SODIUM PANPHARMA SOLUTION; INJECTION | 99/10.2/3530 | PANPHARMA GMBH | active | 31 Dec 2027 |
| HEPANIR INJECTABLE; INJECTION | 2024/10.2/6654 | ACULIFE HEALTHCARE PRIVATE LTD | active | 31 Dec 2027 |
| HEPARIN SODIUM FRESENIUS INJECTABLE; INJECTION | 2011/10.2/4658 | FRESENIUS KABI MANUFACTURING S.A PVT LTD, | active | 31 Dec 2027 |
HEPARIN SODIUM — MCAZ Registration Details
MCAZ (Zimbabwe) has 6 registered products containing HEPARIN SODIUM, of which 6 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track HEPARIN SODIUM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.